Viewing Study NCT00651612


Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2026-03-14 @ 6:24 AM
Study NCT ID: NCT00651612
Status: COMPLETED
Last Update Posted: 2008-04-03
First Post: 2008-04-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients
Sponsor: Allergan
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 190342-024T
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Therapeutic Area Head
Old Organization: Allergan

Collaborators